Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129M
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
28.4M
-
Shares change
-
-1.56M
-
Total reported value, excl. options
-
$19.1M
-
Value change
-
-$1.34M
-
Put/Call ratio
-
0.82
-
Number of buys
-
27
-
Number of sells
-
-40
-
Price
-
$0.67
Significant Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q1 2025
98 filings reported holding ATOS - ATOSSA THERAPEUTICS, INC. - Common Stock as of Q1 2025.
ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.4M shares
of 129M outstanding shares and own 21.93% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (9.63M shares), VANGUARD GROUP INC (6.59M shares), GEODE CAPITAL MANAGEMENT, LLC (2.85M shares), RENAISSANCE TECHNOLOGIES LLC (1.86M shares), STATE STREET CORP (1.73M shares), NORTHERN TRUST CORP (974K shares), Squarepoint Ops LLC (479K shares), UBS Group AG (455K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (440K shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (423K shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.